ArticleQatar medical journal2022

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity.

Sherin Thalappil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.